CECO Environmental Corp. 10-Q Summary
Business Context and Reporting Period
CECO Environmental Corp. is a diversified industrial company providing engineered air, water, emissions-management, filtration, fluid-handling, and energy-transition solutions. The report covers the three and six months ended June 30, 2023, compared with the corresponding 2022 periods. The two reportable segments are Engineered Systems and Industrial Process Solutions.
Key Financial Metrics
| Metric | Q2 2023 | Q2 2022 | Six Months 2023 | Six Months 2022 |
|---|---|---|---|---|
| Net sales | $129.2 million | $105.4 million | $241.7 million | $197.8 million |
| Gross profit | $39.8 million | $31.7 million | $74.7 million | $58.1 million |
| Gross margin | 30.8% | 30.1% | 30.9% | 29.4% |
| Operating income | $8.6 million | $5.7 million | $14.1 million | $11.0 million |
| Operating margin | 6.7% | 5.4% | 5.8% | 5.6% |
| Net income attributable to CECO | $3.7 million | $4.4 million | $5.7 million | $7.2 million |
| Diluted EPS | $0.11 | $0.13 | $0.16 | $0.20 |
Non-GAAP operating income was $11.4 million in Q2 and $19.1 million for the six months, with non-GAAP operating margins of 8.8% and 7.9%, respectively. The filing excludes amortization and earnout expenses, acquisition and integration expenses, executive transition expenses, and restructuring expenses from these measures.
- Orders booked increased 43.5% year over year in Q2 to $162.9 million and increased 12.6% for the six months to $309.0 million.
- Backlog increased to $391.0 million at June 30, 2023 from $311.7 million at December 31, 2022; substantially all backlog is expected to be delivered within 12 to 18 months, although customers may have cancellation rights.
- Engineered Systems Q2 sales increased 30.0% to $87.5 million, while operating income increased to $14.1 million from $9.0 million.
- Industrial Process Solutions Q2 sales increased 9.5% to $41.7 million, but operating income declined to $4.6 million from $5.5 million due primarily to higher material and labor costs.
- Cash and cash equivalents were $47.6 million at June 30, 2023, compared with $45.5 million at December 31, 2022. Restricted cash was $0.9 million.
- Six-month operating cash flow was negative $0.6 million, compared with positive $18.7 million in the prior-year period, primarily reflecting the timing of receivable collections and supplier payments.
- Six-month investing cash outflow was $28.1 million, including $24.1 million for acquisitions and $3.9 million for capital expenditures.
- Total debt was $141.6 million, net of unamortized debt discount, compared with $111.2 million at year-end 2022. The weighted-average stated interest rate was 8.06% at June 30, 2023.
- Credit-facility borrowing availability was $67.2 million before borrowing limitations and $26.4 million after applicable limitations. The company was in compliance with its debt covenants.
- Working capital was $102.8 million, and the current ratio was 1.55 to 1.00 at June 30, 2023.
Material Changes Versus the Prior Comparable Period
- Q2 sales rose 22.6% and six-month sales rose 22.2%, supported by organic growth, acquisitions, higher volume, and favorable project mix.
- Approximately 95% of Q2 sales and 90% of six-month sales were identified by management as organic revenue.
- Gross margins improved by 70 basis points in Q2 and 150 basis points for the six months.
- Net income attributable to CECO declined 15.1% in Q2 and 20.6% for the six months, despite higher operating income, primarily because interest expense increased to $3.8 million in Q2 and $6.2 million for the six months from $1.1 million and $1.9 million, respectively.
- The effective tax rate declined to 19.8% in Q2 and 13.3% for the six months, compared with 28.3% in both prior-year periods.
- CECO acquired Wakefield in January 2023 for $4.1 million in cash plus deferred consideration and acquired Transcend in March 2023 for $20.0 million in cash plus deferred consideration. These acquisitions added approximately $8.0 million of Q2 revenue and $1.0 million of Q2 net income.
- Goodwill increased to $199.7 million from $183.2 million at year-end 2022, primarily from acquisitions and foreign-currency translation.
- No share repurchases occurred during Q2. The remaining authorization under the repurchase program was $13.0 million at June 30, 2023.
Outlook, Risks, Contingencies, and Unusual Items
The filing does not provide explicit quantitative full-year revenue, earnings, or margin guidance. Management expects supply-chain challenges involving raw materials and labor, along with related cost pressures, to continue for the foreseeable future. Management reports taking actions to secure materials from existing and alternate suppliers, but does not guarantee that disruptions will not adversely affect operations.
- Debt is predominantly variable-rate and indexed to SOFR. Management estimates that a hypothetical 10% change in the weighted-average borrowing rate would affect annual earnings and cash flows by approximately $1.2 million.
- Scheduled principal payments under the Credit Facility and joint-venture term debt include $126.3 million in 2026, creating a significant refinancing or repayment requirement.
- The company has asbestos-related litigation pending. There were 261 pending cases at June 30, 2023, compared with 247 at December 31, 2022. Management believes insurance coverage is adequate and does not expect the matters to have a material adverse effect, but coverage and claim volume are uncertain.
- Management identified a material weakness in internal control over financial reporting related to documentation of the review of over-time revenue recognition for certain Engineered Systems contracts. The weakness did not result in a material misstatement or changes to previously issued financial statements, but disclosure controls were deemed ineffective as of June 30, 2023. Remediation is in progress and is not yet complete.
- Goodwill and indefinite-lived intangible assets were not impaired, and no triggering event requiring an interim impairment assessment was identified. The assessment remains sensitive to revenue, operating-profit, terminal-growth, and cost-of-capital assumptions.
- Other risks include fixed-price contract cost overruns, project delays or cancellations, raw-material and labor inflation, acquisition integration, warranty and product-liability claims, regulatory changes, foreign exchange, cybersecurity, and access to capital.
Important Facts for Investors to Verify
- Reconcile the increase in backlog and orders with future revenue conversion, cancellation rights, project margins, and working-capital requirements.
- Assess whether negative operating cash flow and substantially higher receivables can normalize without further borrowing.
- Review debt maturities, variable-rate exposure, covenant headroom, and the company’s ability to refinance the large 2026 maturity concentration.
- Evaluate whether Engineered Systems growth and margin improvement can offset weakness in Industrial Process Solutions.
- Monitor acquisition integration, earnout obligations, goodwill, and intangible-asset amortization.
- Track remediation and auditor or management conclusions regarding the material weakness in revenue-recognition controls.
- Review developments in asbestos litigation, insurance coverage, and other contract, warranty, employment, and tax contingencies.